These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 8396717)
1. Beta 2-adrenergic receptor mutants reveal structural requirements for the desensitization observed with long-term epinephrine treatment. Proll MA; Clark RB; Butcher RW Mol Pharmacol; 1993 Sep; 44(3):569-74. PubMed ID: 8396717 [TBL] [Abstract][Full Text] [Related]
2. Identification of a specific domain in the beta-adrenergic receptor required for phorbol ester-induced inhibition of catecholamine-stimulated adenylyl cyclase. Johnson JA; Clark RB; Friedman J; Dixon RA; Strader CD Mol Pharmacol; 1990 Sep; 38(3):289-93. PubMed ID: 2169578 [TBL] [Abstract][Full Text] [Related]
3. Beta-adrenergic receptor levels and function after growth of S49 lymphoma cells in low concentrations of epinephrine. Proll MA; Clark RB; Goka TJ; Barber R; Butcher RW Mol Pharmacol; 1992 Jul; 42(1):116-22. PubMed ID: 1321952 [TBL] [Abstract][Full Text] [Related]
4. Identification of a specific site required for rapid heterologous desensitization of the beta-adrenergic receptor by cAMP-dependent protein kinase. Clark RB; Friedman J; Dixon RA; Strader CD Mol Pharmacol; 1989 Sep; 36(3):343-8. PubMed ID: 2550773 [TBL] [Abstract][Full Text] [Related]
7. Sensitization of adenylyl cyclase by P2 purinergic and M5 muscarinic receptor agonists in L cells. Johnson JA; Friedman J; Halligan RD; Birnbaumer M; Clark RB Mol Pharmacol; 1991 Oct; 40(4):539-46. PubMed ID: 1921986 [TBL] [Abstract][Full Text] [Related]
8. Stable activation and desensitization of beta 2-adrenergic receptor stimulation of adenylyl cyclase by salmeterol: evidence for quasi-irreversible binding to an exosite. Clark RB; Allal C; Friedman J; Johnson M; Barber R Mol Pharmacol; 1996 Jan; 49(1):182-9. PubMed ID: 8569705 [TBL] [Abstract][Full Text] [Related]
9. Differential expression of the beta-adrenergic receptor modifies agonist stimulation of adenylyl cyclase: a quantitative evaluation. Whaley BS; Yuan N; Birnbaumer L; Clark RB; Barber R Mol Pharmacol; 1994 Mar; 45(3):481-9. PubMed ID: 8145734 [TBL] [Abstract][Full Text] [Related]
10. Characterization of agonist stimulation of cAMP-dependent protein kinase and G protein-coupled receptor kinase phosphorylation of the beta2-adrenergic receptor using phosphoserine-specific antibodies. Tran TM; Friedman J; Qunaibi E; Baameur F; Moore RH; Clark RB Mol Pharmacol; 2004 Jan; 65(1):196-206. PubMed ID: 14722251 [TBL] [Abstract][Full Text] [Related]
11. Mutant constructs of the beta-adrenergic receptor that are uncoupled from adenylyl cyclase retain functional activation of Na-H exchange. Barber DL; Ganz MB; Bongiorno PB; Strader CD Mol Pharmacol; 1992 Jun; 41(6):1056-60. PubMed ID: 1319545 [TBL] [Abstract][Full Text] [Related]
12. Epinephrine-induced sequestration of the beta-adrenergic receptor in cultured S49 WT and cyc- lymphoma cells. Clark RB; Friedman J; Prashad N; Ruoho AE J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(1):97-119. PubMed ID: 2984267 [TBL] [Abstract][Full Text] [Related]
13. The human beta 3-adrenergic receptor is resistant to short term agonist-promoted desensitization. Nantel F; Bonin H; Emorine LJ; Zilberfarb V; Strosberg AD; Bouvier M; Marullo S Mol Pharmacol; 1993 Apr; 43(4):548-55. PubMed ID: 8386307 [TBL] [Abstract][Full Text] [Related]
14. Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit. Zeiders JL; Seidler FJ; Slotkin TA J Mol Cell Cardiol; 1997 Feb; 29(2):603-15. PubMed ID: 9140819 [TBL] [Abstract][Full Text] [Related]
15. [Molecular mechanisms of regulatory action of adrenergic receptor agonists on functional activity of adenylyl cyclase signaling system of the ciliates Dileptus anser and Tetrahymena pyriformis]. Shpakov AO; Derkach KV; Uspenskaia ZI; Shpakova EA; Kuznetsova LA; Plesneva SA; Pertseva MN Tsitologiia; 2004; 46(4):317-25. PubMed ID: 15346790 [TBL] [Abstract][Full Text] [Related]
16. Distinct receptor domains determine subtype-specific coupling and desensitization phenotypes for human beta1- and beta2-adrenergic receptors. Rousseau G; Nantel F; Bouvier M Mol Pharmacol; 1996 Apr; 49(4):752-60. PubMed ID: 8609905 [TBL] [Abstract][Full Text] [Related]
17. cAMP-dependent protein kinase and protein kinase C consensus site mutations of the beta-adrenergic receptor. Effect on desensitization and stimulation of adenylylcyclase. Yuan N; Friedman J; Whaley BS; Clark RB J Biol Chem; 1994 Sep; 269(37):23032-8. PubMed ID: 8083204 [TBL] [Abstract][Full Text] [Related]
18. Role of specific protein kinase C isoforms in modulation of beta1- and beta2-adrenergic receptors. Guimond J; Mamarbachi AM; Allen BG; Rindt H; Hébert TE Cell Signal; 2005 Jan; 17(1):49-58. PubMed ID: 15451024 [TBL] [Abstract][Full Text] [Related]
19. Dual signaling potential is common among Gs-coupled receptors and dependent on receptor density. Zhu X; Gilbert S; Birnbaumer M; Birnbaumer L Mol Pharmacol; 1994 Sep; 46(3):460-9. PubMed ID: 7935326 [TBL] [Abstract][Full Text] [Related]
20. Epinephrine desensitization of adenylate cyclase from cyc- and S49 cultured lymphoma cells. Green DA; Friedman J; Clark RB J Cyclic Nucleotide Res; 1981; 7(3):161-72. PubMed ID: 7287968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]